Rosetta Genomics Ltd. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Rosetta Genomics Ltd. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$14.53 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-03-16.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2015-03-16
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|
| 2014-12-31 | -$14.53M 20-F · filed 2015-03-16 | |
| 2013-12-31 | -$12.90M 20-F · filed 2015-03-16 | |
| 2013-06-30 | -$6.29M 6-K · filed 2013-09-09 | |
| 2012-12-31 | -$10.46M 20-F · filed 2015-03-16 | |
| 2012-06-30 | -$6.58M 6-K · filed 2013-09-09 | |
| 2011-12-31 | -$10.10M 20-F · filed 2014-03-31 | |
| 2011-06-30 | -$4.53M 6-K · filed 2012-09-28 | |
| 2010-12-31 | -$15.14M 20-F · filed 2013-03-22 | |
| 2009-12-31 | -$16.50M 6-K · filed 2012-12-07 |